9-127682510-G-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_003165.6(STXBP1):c.1652G>C(p.Arg551Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R551H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003165.6 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 4Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Dravet syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autism spectrum disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STXBP1 | ENST00000373302.8 | c.1652G>C | p.Arg551Pro | missense_variant | Exon 18 of 20 | 1 | NM_003165.6 | ENSP00000362399.3 | ||
| STXBP1 | ENST00000373299.5 | c.1652G>C | p.Arg551Pro | missense_variant | Exon 18 of 19 | 1 | NM_001032221.6 | ENSP00000362396.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
p.Arg551Pro (CGC>CCC): c.1652 G>C in exon 18 of the STXBP1 gene (NM_003165.2)The novel R551P missense change in the STXBP1 gene has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. However, a different amino acid substitution at the same codon, R551C, was previously reported as a de novo change in a patient with an autism spectrum disorder, although no additional information was provided regarding the patient's phenotype (Neale et al., 2012). The R551C variant subsequently has been reported as a de novo pathogenic variant in a child with infantile epileptic encephalopathy, intellectual disability, and ataxia (Weckhuysen et al., 2013). The R551P variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R551P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. R551P alters a highly conserved position in the protein, and other missense variants have been reported in this region of the protein in the Human Gene Mutation Database in association with epilepsy (Stenson et al., 2014). Additionally, in silico analysis predicts this variant is probably damaging to the protein structure/function. The variant is found in EPILEPSY panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at